KV
Karan Vipul Bhagat
About Karan Vipul Bhagat
Data last updated:
Karan Vipul Bhagat is a Director at Novo Medi Sciences Private Limited (since 2016), Director at Novo Biologicals Private Limited (since 2023) and Designated Partner at Novo Biosciences Llp (since 2023). The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹96.23 Cr; the largest is Novo Medi Sciences Private Limited at ₹96.23 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novo Medi Sciences Private Limited U33110MH2013PTC245027 | Director | 30 Sep 2016 | 2013 | ₹96.23 Cr (FY 2023) | Active |
 Novo Biologicals Private Limited U46497MH2023PTC412674 | Director | 23 Oct 2023 | 2023 | ₹1,305 (FY 2025) | Active |
| Novo Biosciences Llp ACC-3932 | Designated Partner | 07 Aug 2023 | 2023 | Active |
Board colleagues of Karan Vipul Bhagat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anju Sunil Kaudanya | 01294050 | Novo Medi Sciences Private Limited , Novo Biologicals Private Limited | Director |
| Forum Vipulkumar Bhagat | 07288677 | Novo Medi Sciences Private Limited , Novo Biologicals Private Limited | Director |
| Vipulkumar Rameshchandra Bhagat | 01756677 | Novo Medi Sciences Private Limited , Novo Biologicals Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karan Vipul Bhagat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karan Vipul Bhagat
Karan Vipul Bhagat currently holds 3 directorships: Novo Medi Sciences Private Limited (Director, since 30 Sep 2016, revenue ₹96.23 Cr (FY 2023)); Novo Biologicals Private Limited (Director, since 23 Oct 2023, revenue ₹1,305 (FY 2025)); Novo Biosciences Llp (Designated Partner, since 07 Aug 2023).
Karan Vipul Bhagat was first appointed on 30 Sep 2016 as Director at Novo Medi Sciences Private Limited. The most recent appointment on record is 23 Oct 2023 at Novo Biologicals Private Limited.
The 2 current companies of Karan Vipul Bhagat that report revenue have a combined latest revenue of ₹96.23 Cr: Novo Medi Sciences Private Limited ₹96.23 Cr (FY 2023); Novo Biologicals Private Limited ₹1,305 (FY 2025).
The current boards of Karan Vipul Bhagat's companies include Anju Sunil Kaudanya (Novo Medi Sciences Private Limited), Forum Vipulkumar Bhagat (Novo Medi Sciences Private Limited), Vipulkumar Rameshchandra Bhagat (Novo Medi Sciences Private Limited).